ARTV

Artiva Biotherapeutics, Inc. $4.19 as of 2026-11-02
Model view — historical tendencies for the days ahead, not a forecast
Next 1 day
+1.1%
Next 1 week
-3.5%
Next 1 month
+4.0%
Seasonality
Not enough history
20-year seasonality chart →
Mean reversion
Deeply oversold — RSI(2) at 2
RSI(2) under 15 is oversold (this name has historically bounced); over 85 is overbought. Its dip-buy edge in history is -0.61%/day.
Mean-reversion stats →
1-month breakdown — Market · β 1.69 +4.0%
$6M/day volume 139% volatility +6% 1-year -76% from ATH
52-week range · 11% of the way up · -71% from the high
$2.96$14.53

Earnings Full history →

Next report 2026-11-12 (Thursday, after close, in 9 days) · EPS est. -0.53.

1-day std dev
10.3%
Finished up
44%
Biggest pop
+17.3%
Biggest drop
-13.0%

Standard deviation of the close-to-close move over the last 9 reports. History, not a forecast.

ReportedEst.Actual SurpriseGap Day 1Day 5
2026-08-06 beat -0.64 -0.63 +1.9% +0.4% -2.7% -1.1%
2026-05-08 miss -0.84 -0.95 -12.7% -3.8% -13.0% -21.9%
2026-03-10 miss -0.80 -0.84 -5.0% +0.7% +17.3% -4.6%
2025-11-12 miss -0.80 -0.88 -10.0% +0.0% +10.9% -5.6%
2025-08-07 -0.77 — — -2.8% -8.0% -5.9%
2025-08-06 miss -0.77 -0.87 -13.0% -2.8% -8.0% -5.9%
2025-05-08 miss -0.62 -0.83 -33.9% +3.3% +3.8% +1.4%
2024-11-12 miss -0.63 -0.87 -37.5% +1.5% -10.5% -16.1%
2024-08-29 beat -1.59 -0.64 +59.9% -3.9% +2.1% +6.2%

Not investment advice.